Geoffrey M. Price - Feb 21, 2023 Form 4 Insider Report for Oak Street Health, Inc. (OSH)

Role
Chief Innovation Officer, Director
Signature
/s/ Robert Guenthner, attorney-in-fact for Geoffrey Price
Stock symbol
OSH
Transactions as of
Feb 21, 2023
Transactions value $
-$6,145,154
Form type
4
Date filed
2/23/2023, 06:00 PM
Previous filing
Feb 9, 2023
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSH Common Stock, $0.001 par value Options Exercise $1.05M +50K +1.29% $21.00 3.92M Feb 21, 2023 Direct F1
transaction OSH Common Stock, $0.001 par value Sale -$1.77M -50K -1.27% $35.32 3.87M Feb 21, 2023 Direct F1, F2
transaction OSH Common Stock, $0.001 par value Options Exercise $2.58M +123K +3.17% $21.00 4M Feb 22, 2023 Direct F1
transaction OSH Common Stock, $0.001 par value Sale -$4.38M -123K -3.08% $35.61 3.87M Feb 22, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSH Employee Stock Option (Right to Buy) Options Exercise -$1.05M -50K -2.33% $21.00 2.09M Feb 21, 2023 Common Stock, par value $0.001 50K $21.00 Direct F1, F4
transaction OSH Employee Stock Option (Right to Buy) Options Exercise -$2.58M -123K -5.88% $21.00 1.97M Feb 22, 2023 Common Stock, par value $0.001 123K $21.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.265 to $35.375, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (2).
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.600 to $35.640, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (3).
F4 The reported securities include the aggregate options, all of which were issued at the time of the Issuer's initial public offering, held by the Reporting Person, a portion of which remains subject to vesting.